Serotonin and schizophrenia: correlations between serotonergic activity and schizophrenic motor behavior.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Psychiatry Research

• Publication date

  1985-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0165-1781(85)90018-6PMID 2408290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders.

  1983cited by this paper
• Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia.

  1982cited by this paper
• Middle ear muscle activity during REM sleep in schizophrenic, schizoaffective and depressed patients.

  1982cited by this paper
• Middle ear muscle activity during REM sleep in schizophrenic, schizoaffective and depressed patients.

  1982cited by this paper
• Blood tryptophan metabolism in chronic schizophrenics.

  1981cited by this paper
• Asperger's syndrome: a clinical account

  1981cited by this paper
• The role of 5-hydroxytryptamine in dopamine-dependent stereotyped behaviour.

  1981cited by this paper
• Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.

  1980cited by this paper
• Determination of tryptophan and metabolites in rat brain and pineal tissue by reversed-phase high-performance liquid chromatography with electrochemical detection.

  1980cited by this paper
• Schizoid personality in childhood: a controlled follow-up study

  1980cited by this paper
• Relationships in Healthy Volunteers Between Concentrations of Monoamine Metabolites in Cerebrospinal Fluid and Family History of Psychiatric Morbidity

  1980cited by this paper
• Selected ion monitoring assay for biogenic amine metabolites and probenecid in human lumbar cerebrospinal fluid.

  1979cited by this paper
• Serotonergic facilitation of facial motoneuron excitation.

  1979cited by this paper
• Simultaneous determination of indole- and catecholamines in small brain regions in the rat using a weak cation exchange resin.

  1976cited by this paper
• Brain stem and spinal cord mediation of a serotonergic behavioral syndrome.

  1975cited by this paper
• ABNORMALITIES OF CEREBRAL BLOOD FLOW DISTRIBUTION IN PATIENTS WITH CHRONIC SCHIZOPHRENIA

  1974cited by this paper
• Eye-tracking dysfunctions in schizophrenic patients and their relatives.

  1974cited by this paper
• Heredity and environment in the functional psychoses

  1967cited by this paper
• Major psychiatric disorders. A four-dimensional model.

  1967cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper
• Blood platelet 5-hydroxytryptamine levels in psychiatric patients.

  1960cited by this paper

• The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system

  2005cites this paper
• [Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy].

  2005cites this paper
• Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD)

  2004cites this paper
• REPETITIVE BEHAVIORS IN CHRONIC SCHIZOPHRENIA: USING THE JAPANESE VERSION OF THE ELGIN BEHAVIOR RATING SCALE (JEBRS)

  2003cites this paper
• Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment.

  2002cites this paper
• The Role of Serotonin in Violence and Schizophrenia: Implications for Risk Assessment

  2000cites this paper
• Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

  1999cites this paper
• Co‐administration of sertraline and haloperidol

  1998cites this paper
• Anxiolytic effects of low-dose clomipramine in highly anxious healthy volunteers assessed by frontal midline theta activity.

  1998cites this paper
• BASES BIOLÓGICAS DE LA ESQUIZOFRENIA: ASPECTOS NEUROQUÍMICOS Y NEUROANATÓMICOS

  1998cites this paper
• The role of serotonin in schizophrenia.

  1995cites this paper
• Pharmacotherapy of schizophrenia: a review.

  1994cites this paper
• Distribution of cocaine recognition sites in rat brain: in vitro and ex vivo autoradiography with [125I]RTI-55.

  1994cites this paper
• Are there neurochemical indicators of risk for schizophrenia?

  1994cites this paper
• Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity.

  1994cites this paper
• Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.

  1993cites this paper
• Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.

  1993cites this paper
• m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.

  1993cites this paper
• Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.

  1993cites this paper
• Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.

  1993cites this paper
• Effect of the serotonin agonist, MK-212, on body temperature in schizophrenia.

  1992cites this paper
• Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding

  1992cites this paper
• Effects of mianserin in chronic schizophrenia.

  1992cites this paper
• The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome.

  1991cites this paper
• "Down regulation" of 5-HT2 receptors: possible role of melatonin and significance for negative schizophrenia.

  1991cites this paper
• The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies.

  1990cites this paper
• Effects of mianserin on negative symptoms in schizophrenia.

  1990cites this paper
• Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient.

  1990cites this paper
• 5-HIAA in Cerebrospinal Fluid and Deficit Schizophrenic Characteristics

  1990cites this paper
• Neuroendocrine aspects of the serotonergic hypothesis of depression.

  1989cites this paper
• Correlations between the MMPI and the Brief Psychiatric Rating Scale in schizophrenic and schizoaffective patients.

  1989cites this paper
• Inhibiting noradrenergic overactivity by inhibition of thromboxane and concomitant activation of opiate receptors via dietary means.

  1989cites this paper
• The role of serotonin in schizophrenia.

  1988cites this paper
• Schizophrenia: Instability in Norepinephrine, Serotonin, and γ-Aminobutyric Acid Systems

  1988cites this paper
• Schizophrenia: instability in norepinephrine, serotonin, and gamma-aminobutyric acid systems.

  1988cites this paper
• Biological studies in schizophrenia.

  1987influential citation
• Biological Studies of the Nosology of the Major Psychoses: A Status Report on the Schizoaffective Disorders

  1986cites this paper
• Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity.

  1986cites this paper
• Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.

  1986cites this paper
• Chapter 1. Atypical Antipsychotic Agents

  1986cites this paper